umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Recurrent stroke: risk factors, predictors and prognosis
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin, Medicin.ORCID-id: 0000-0003-1598-4690
2016 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Background Many risk factors for stroke are well characterized and might, at least to some extent, be similar for first-ever stroke and for recurrent stroke events. However, previous studies have shown heterogeneous results on predictors and rates of stroke recurrence. Patients who survive spontaneous intracerebral hemorrhage (ICH) often have compelling indications for antithrombotic (AT) treatment (antiplatelet (AP) and/or anticoagulant (AC) treatment), but due to controversy of the decision to treat, a large proportion of these patients are untreated. In the absence of evidence from randomized controlled trials (RCTs), there is need for more high- quality observational data on the clinical impact of, and optimal timing of AT in ICH survivors. The aims of this thesis were to assess time trends in stroke recurrence, to determine the factors associated with an increased risk of stroke recurrence – including socioeconomic factors – and to determine to what extent ICH survivors with and without atrial fibrillation (AF) receive AT treatment and to determine the optimal timing (if any) of such treatment. 

Methods The population-based Monitoring Trends and Determinants of Cardiovascular Disease (MONICA) stroke incidence register was used to assess the epidemiology and predictors of stroke recurrence after ischemic stroke (IS) and ICH from 1995 to 2008 in northern Sweden. Riksstroke, the Swedish stroke register, linked with the National Patient Register and the Swedish Dispensed Drug Register, made it possible to identify survivors of first-ever ICH from 2005 to 2012 with and without concomitant AF to investigate to what extent these patients were prescribed AP and AC therapy. The optimal timing of initiating treatment following ICH in patients with AF 2005–2012 was described through separate cumulative incidence functions for severe thrombotic and hemorrhagic events and for the combined endpoint “vascular death or non-fatal stroke”. Riksstroke data on first-ever stroke patients from 2001 to 2012 was linked to the Longitudinal Integration Database for Health Insurance and Labour market studies to add information on education and income to investigate the relationship between socioeconomic status and risk of recurrence.

Results Comparison between the cohorts of 1995–1998 and 2004–2008 showed declining risk of stroke recurrence (hazard ratio: 0.64, 95% confidence interval (CI): 0.52-0.78) in northern Sweden. Significant factors associated with an increased risk of stroke recurrence were age and diabetes. Following ICH, a majority (62%) of recurrent stroke events were ischemic.  The nationwide Riksstroke study confirmed the declining incidence, and it further concluded that low income, primary school as highest attained level of education, and living alone were associated with a higher risk of recurrence beyond the acute phase. The inverse effects of socioeconomic status on risk of recurrence did not differ between men and women and persisted over the study period.

Of Swedish ICH-survivors with AF, 8.5% were prescribed AC and 36.6% AP treatment, within 6 months of ICH. In patients with AF, predictors of AC treatment were less severe ICH, younger age, previous anticoagulation, valvular disease and previous IS. High CHA2DS2-VASc scores did not seem to correlate with AC treatment. We observed both an increasing proportion of AC treatment at time of the initial ICH (8.1% in 2006 compared with 14.6% in 2012) and a secular trend of increasing AC use one year after discharge (8.3% in 2006 versus 17.2% in 2011) (p<0.001 assuming linear trends). In patients with high cardiovascular event risk, AC treatment was associated with a reduced risk of vascular death and non-fatal stroke with no significantly increased risk of severe hemorrhage. The benefit appeared to be greatest when treatment was started 7–8 weeks after ICH. For high-risk women, the total risk of vascular death or stroke recurrence within three years was 17.0% when AC treatment was initiated eight weeks after ICH and 28.6% without any antithrombotic treatment (95% CI for difference: 1.4% to 21.8%). For high-risk men, the corresponding risks were 14.3% vs. 23.6% (95% CI for difference: 0.4% to 18.2%).

Conclusion Stroke recurrence is declining in Sweden, but it is still common among stroke survivors and has a severe impact on patient morbidity and mortality. Age, diabetes and low socioeconomic status are predictors of stroke recurrence. Regarding ICH survivors with concomitant AF, physicians face the clinical dilemma of balancing the risks of thrombosis and bleeding. In awaiting evidence from RCTs, our results show that AC treatment in ICH survivors with AF was initiated more frequently over the study period, which seems beneficial, particularly in high-risk patients. The optimal timing of anticoagulation following ICH in AF patients seems to be around 7–8 weeks following the hemorrhage.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå Universitet , 2016. , s. 66
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 1847
Nyckelord [en]
stroke, risk factors, atrial fibrillation, anticoagulant, antiplatelet, intracerebral hemorrhage, stroke recurrence, socioeconomic status
Nationell ämneskategori
Annan klinisk medicin
Forskningsämne
medicin
Identifikatorer
URN: urn:nbn:se:umu:diva-127304ISBN: 978-91-7601-579-7 (tryckt)OAI: oai:DiVA.org:umu-127304DiVA, id: diva2:1045473
Disputation
2016-12-02, Hörsal Betula, Norrlands Universitetssjukhus, Umeå, 13:00 (Svenska)
Opponent
Handledare
Forskningsfinansiär
Forte, Forskningsrådet för hälsa, arbetsliv och välfärd, 2011-0657Vetenskapsrådet, 2011-2395Tillgänglig från: 2016-11-11 Skapad: 2016-11-07 Senast uppdaterad: 2018-06-09Bibliografiskt granskad
Delarbeten
1. Long-Term Risk and Predictors of Recurrent Stroke Beyond the Acute Phase
Öppna denna publikation i ny flik eller fönster >>Long-Term Risk and Predictors of Recurrent Stroke Beyond the Acute Phase
2014 (Engelska)Ingår i: Stroke, ISSN 0039-2499, E-ISSN 1524-4628, Vol. 45, nr 6, s. 1839-1841Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background and Purpose-Previous studies have shown heterogeneous results on predictors and rates of stroke recurrence. This study set out to investigate the long-term risk and predictors of recurrent stroke in Northern Sweden 1995 to 2008.

Methods-In the population-based Monitoring Trends and Determinants of Cardiovascular Disease (MONICA) stroke incidence registry, stroke survivors of either ischemic stroke or intracerebral hemorrhage were followed for recurrent stroke or death. Cox regression was used to identify predictors of stroke recurrence.

Results-The study comprised 6700 patients and 26 597 person-years. During follow-up, 928 (13.9%) patients had a recurrent stroke. Comparison between the first time period (1995-1998) and the last (2004-2008) showed declined risk of stroke recurrence (hazard ratio, 0.64 [95% confidence interval, 0.52-0.78]). Previous myocardial infarction was less prevalent in the most recent cohort (P<0.001). Predictors of stroke recurrence were age (hazard ratio, 1.03 [95% confidence interval, 1.02-1.04]) and diabetes mellitus (hazard ratio, 1.34 [95% confidence interval, 1.15-1.57]). After an index intracerebral hemorrhage (n=815), a major part of recurrent events were ischemic (63%), and compared with the ischemic stroke group (n=5885), a tendency toward lower risk of recurrence was observed.

Conclusions-Despite declining recurrence rates in this relatively young stroke population, almost one third are either dead or have experienced a second stroke in 5 years.

Nyckelord
epidemiology, stroke
Nationell ämneskategori
Kardiologi
Identifikatorer
urn:nbn:se:umu:diva-91150 (URN)10.1161/STROKEAHA.114.005060 (DOI)000337090700049 ()
Tillgänglig från: 2014-07-16 Skapad: 2014-07-15 Senast uppdaterad: 2018-06-07Bibliografiskt granskad
2. Antithrombotic treatment following intracerebral hemorrhage in patients with and without atrial fibrillation. A nationwide study based on Riksstroke
Öppna denna publikation i ny flik eller fönster >>Antithrombotic treatment following intracerebral hemorrhage in patients with and without atrial fibrillation. A nationwide study based on Riksstroke
Visa övriga...
2015 (Engelska)Ingår i: International Journal of Stroke, ISSN 1747-4930, E-ISSN 1747-4949, Vol. 10, s. 294-295Artikel i tidskrift, Meeting abstract (Övrigt vetenskapligt) Published
Nationell ämneskategori
Kardiologi
Identifikatorer
urn:nbn:se:umu:diva-108168 (URN)000359304002050 ()
Anmärkning

Supplement: 2 Special Issue: SI Meeting Abstract: ESOC-1343

Tillgänglig från: 2015-09-09 Skapad: 2015-09-04 Senast uppdaterad: 2018-06-07Bibliografiskt granskad
3. Optimal timing of anticoagulant treatment following intracerebral hemorrhage in patients with atrial fibrillation
Öppna denna publikation i ny flik eller fönster >>Optimal timing of anticoagulant treatment following intracerebral hemorrhage in patients with atrial fibrillation
Visa övriga...
(Engelska)Manuskript (preprint) (Övrigt vetenskapligt)
Nationell ämneskategori
Kardiologi
Identifikatorer
urn:nbn:se:umu:diva-127404 (URN)
Tillgänglig från: 2016-11-10 Skapad: 2016-11-10 Senast uppdaterad: 2018-06-09
4. Socioeconomic status and the risk of stroke recurrence. Persisting gaps observed in a nationwide Swedish study 2001-2012
Öppna denna publikation i ny flik eller fönster >>Socioeconomic status and the risk of stroke recurrence. Persisting gaps observed in a nationwide Swedish study 2001-2012
Visa övriga...
(Engelska)Manuskript (preprint) (Övrigt vetenskapligt)
Abstract
Nationell ämneskategori
Kardiologi
Identifikatorer
urn:nbn:se:umu:diva-127405 (URN)
Tillgänglig från: 2016-11-10 Skapad: 2016-11-10 Senast uppdaterad: 2018-06-09

Open Access i DiVA

omslag(1163 kB)41 nedladdningar
Filinformation
Filnamn COVER01.pdfFilstorlek 1163 kBChecksumma SHA-512
28d60ba395932d4f48f559701546d6c9fa030dc5cab1a4997af05e67145f8d357458b82ea4397b2fa1dbdb48f6220b869ef89fbe3b230c546134ffefb9878f67
Typ coverMimetyp application/pdf
spikblad(74 kB)70 nedladdningar
Filinformation
Filnamn SPIKBLAD01.pdfFilstorlek 74 kBChecksumma SHA-512
1f78e790054a0504c9a9ca4dce4104b45cecf45da0230a7f949347bc323cfd099326fe297a9c5560cfcd351ff2e409a68f6b16e0ce6d3fe518991750a8daa2fa
Typ spikbladMimetyp application/pdf
fulltext(1768 kB)477 nedladdningar
Filinformation
Filnamn FULLTEXT02.pdfFilstorlek 1768 kBChecksumma SHA-512
efc38f36e7e882e97462fa81e93333920978386d342d9aa7140932a7578dc0f4867bafea8593c5bafea020760e5fe6976fec860f96945339b1830e7c7488ce28
Typ fulltextMimetyp application/pdf

Personposter BETA

Pennlert, Johanna

Sök vidare i DiVA

Av författaren/redaktören
Pennlert, Johanna
Av organisationen
Medicin
Annan klinisk medicin

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 477 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

isbn
urn-nbn

Altmetricpoäng

isbn
urn-nbn
Totalt: 2290 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf